Estamos realizando la búsqueda. Por favor, espere...
1582
37
170
29108
4409
2600
347
389
Abstract: Non-alcoholic fatty liver disease (NAFLD) is becoming a major cause of liver disease-related morbidity, as well as mortality. Importantly, NAFLD is considered a mediator of systemic diseases including cardiovascular disease. Its prevalence is expected to increase, mainly due to its close association with obesity and type 2 diabetes mellitus (T2D). In addition, T2D and NAFLD share common pathophysiological mechanisms, and one can lead to or worsen the other. Therefore, a close collaboration between primary care physician, endocrinologists and hepatologists is essential to optimize the management of patients with NAFLD and T2D. Here, we summarize relevant aspects about NAFLD and T2D that all clinician managing these patients should know as well as current therapeutic options for the treatment of T2D associated with NAFLD.
Fuente: Gastroenterología y Hepatología, 2023, 46, 815-825
Editorial: Elsevier
Año de publicación: 2023
Nº de páginas: 11
Tipo de publicación: Artículo de Revista
DOI: 10.1016/j.gastrohep.2022.12.002
ISSN: 0210-5705
Url de la publicación: https://doi.org/10.1016/j.gastrohep.2022.12.002
Leer publicación
GENUA, IDOIA
PAULA IRUZUBIETA COZ
JUAN CARLOS RODRÍGUEZ DUQUE
PÉREZ, ANTONIO
JAVIER CRESPO GARCIA
Volver